Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 208,724	$ 173,719
Restricted Cash and Cash Equivalents, Current	1,500	0
Short-term marketable securities	218,690	147,608
Accounts receivable, net of allowance of $773 and $736 as of September 30, 2023 and December 31, 2022, respectively	103,428	121,795
Prepaid expenses and other current assets	29,836	30,216
Total current assets	562,178	473,338
Long-term marketable securities	33,648	59,206
Property and equipment, net	36,160	47,428
Operating leases - right of use asset	25,211	33,752
Deferred tax assets, net	57,171	45,412
Intangible assets, net	10,486	12,801
Goodwill	7,447	7,447
Noncurrent restricted cash	1,200	2,700
Other noncurrent assets	18,360	18,857
Total assets	751,861	700,941
Current liabilities:
Accounts payable	1,165	2,808
Accrued liabilities	49,838	42,592
Deferred revenues, current	307,179	293,728
Operating lease liabilities, current	12,309	13,060
Total current liabilities	370,491	352,188
Deferred revenues, noncurrent	32,287	23,490
Operating lease liabilities, noncurrent	19,655	29,121
Other noncurrent liabilities	6,511	7,013
Total liabilities	428,944	411,812
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock: $0.001 par value; 20,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022	0	0
Common stock: $0.001 par value; 1,000,000 shares authorized, 36,796 and 37,362 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	37	37
Additional paid-in capital	568,088	512,486
Accumulated other comprehensive loss	(867)	(1,947)
Accumulated deficit	(244,341)	(221,447)
Total stockholders’ equity	322,917	289,129
Total liabilities and stockholders’ equity	$ 751,861	$ 700,941